(Q30277652)

English

Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 June 2017

Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial (English)

1 reference

Europe PubMed Central

14 June 2017

phase I clinical trial

0 references

vector-borne disease

0 references

retinitis pigmentosa

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

William W Hauswirth

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Fowzan S Alkuraya

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Nicola G Ghazi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Emad B Abboud

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Sawsan R Nowilaty

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Hisham Alkuraya

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Abdulrahman Alhommadi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Huimin Cai

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Rui Hou

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Sanford L Boye

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Abdulrahman Almaghamsi

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Fahad Al Saikhan

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Hassan Al-Dhibi

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

David Birch

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Christopher Chung

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Matthew M LaVail

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Douglas Vollrath

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Kirsten Erger

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Wenqiu Wang

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Thomas Conlon

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Kang Zhang

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

29 January 2016

1 reference

Europe PubMed Central

14 June 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

135

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

327-343

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26825853%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

https://scigraph.springernature.com/pub.10.1007/s00439-016-1637-y

0 references

Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Impairment of the transient pupillary light reflex in Rpe65(-/-) mice and humans with leber congenital amaurosis

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

The human visual cortex responds to gene therapy-mediated recovery of retinal function

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Effect of gene therapy on visual function in Leber's congenital amaurosis

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Long-term effect of gene therapy on Leber's congenital amaurosis

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

The molecular basis of human retinal and vitreoretinal diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Vision 1 year after gene therapy for Leber's congenital amaurosis

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Genes and mutations causing retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

The Detection of Motion by Blind Subjects With the Epiretinal 60-Electrode (Argus II) Retinal Prosthesis.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Mertk triggers uptake of photoreceptor outer segments during phagocytosis by cultured retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Prevalence of posterior subcapsular lens opacities in patients with retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Gene therapy clinical trials worldwide to 2012 - an update.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST).

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Gene Therapy for MERTK-Associated Retinal Degenerations.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Safety and efficacy of gene transfer for Leber's congenital amaurosis

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Preliminary results of gene therapy for retinal degeneration.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Expanding the clinical, allelic, and locus heterogeneity of retinal dystrophies.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Full-field stimulus testing (FST) to quantify visual perception in severely blind candidates for treatment trials.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Gene supplementation therapy for recessive forms of inherited retinal dystrophies.

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Progress and problems with the use of viral vectors for gene therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

History of gene therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait

1 reference

https://api.crossref.org/works/10.1007%2FS00439-016-1637-Y

21 January 2018

Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/26825853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cataract extraction outcomes and the prevalence of zonular insufficiency in retinitis pigmentosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/26825853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26825853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Case 15-2009: a man with coma after cardiac arrest

1 reference

https://pubmed.ncbi.nlm.nih.gov/26825853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advances in gene therapy technologies to treat retinitis pigmentosa.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26825853

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30277652&oldid=1983076603"